GSK plc Statistics
Total Valuation
GSK plc has a market cap or net worth of GBP 58.32 billion. The enterprise value is 70.83 billion.
Market Cap | 58.32B |
Enterprise Value | 70.83B |
Important Dates
The last earnings date was Friday, January 31, 2025.
Earnings Date | Jan 31, 2025 |
Ex-Dividend Date | Feb 20, 2025 |
Share Statistics
GSK plc has 4.08 billion shares outstanding. The number of shares has increased by 0.75% in one year.
Current Share Class | n/a |
Shares Outstanding | 4.08B |
Shares Change (YoY) | +0.75% |
Shares Change (QoQ) | +0.10% |
Owned by Insiders (%) | 0.09% |
Owned by Institutions (%) | 87.06% |
Float | 3.94B |
Valuation Ratios
The trailing PE ratio is 22.97 and the forward PE ratio is 8.45. GSK plc's PEG ratio is 1.25.
PE Ratio | 22.97 |
Forward PE | 8.45 |
PS Ratio | 1.86 |
PB Ratio | 4.27 |
P/TBV Ratio | n/a |
P/FCF Ratio | 11.31 |
P/OCF Ratio | n/a |
PEG Ratio | 1.25 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.67, with an EV/FCF ratio of 13.74.
EV / Earnings | 27.51 |
EV / Sales | 2.26 |
EV / EBITDA | 7.67 |
EV / EBIT | 10.79 |
EV / FCF | 13.74 |
Financial Position
The company has a current ratio of 0.78, with a Debt / Equity ratio of 1.30.
Current Ratio | 0.78 |
Quick Ratio | 0.52 |
Debt / Equity | 1.30 |
Debt / EBITDA | 1.84 |
Debt / FCF | 3.30 |
Interest Coverage | 9.82 |
Financial Efficiency
Return on equity (ROE) is 22.80% and return on invested capital (ROIC) is 13.49%.
Return on Equity (ROE) | 22.80% |
Return on Assets (ROA) | 6.93% |
Return on Invested Capital (ROIC) | 13.49% |
Return on Capital Employed (ROCE) | 17.39% |
Revenue Per Employee | 446,875 |
Profits Per Employee | 36,675 |
Employee Count | 70,212 |
Asset Turnover | 0.53 |
Inventory Turnover | 1.58 |
Taxes
In the past 12 months, GSK plc has paid 754.00 million in taxes.
Income Tax | 754.00M |
Effective Tax Rate | 14.39% |
Stock Price Statistics
The stock price has decreased by -14.83% in the last 52 weeks. The beta is 0.34, so GSK plc's price volatility has been lower than the market average.
Beta (5Y) | 0.34 |
52-Week Price Change | -14.83% |
50-Day Moving Average | 1,376.74 |
200-Day Moving Average | 1,496.57 |
Relative Strength Index (RSI) | 53.40 |
Average Volume (20 Days) | 8,985,923 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, GSK plc had revenue of GBP 31.38 billion and earned 2.58 billion in profits. Earnings per share was 0.62.
Revenue | 31.38B |
Gross Profit | 22.53B |
Operating Income | 6.57B |
Pretax Income | 3.48B |
Net Income | 2.58B |
EBITDA | 9.24B |
EBIT | 6.57B |
Earnings Per Share (EPS) | 0.62 |
Balance Sheet
The company has 3.89 billion in cash and 16.99 billion in debt, giving a net cash position of -13.10 billion or -3.21 per share.
Cash & Cash Equivalents | 3.89B |
Total Debt | 16.99B |
Net Cash | -13.10B |
Net Cash Per Share | -3.21 |
Equity (Book Value) | 13.09B |
Book Value Per Share | 3.35 |
Working Capital | -4.70B |
Cash Flow
In the last 12 months, operating cash flow was 6.55 billion and capital expenditures -1.40 billion, giving a free cash flow of 5.16 billion.
Operating Cash Flow | 6.55B |
Capital Expenditures | -1.40B |
Free Cash Flow | 5.16B |
FCF Per Share | 1.26 |
Margins
Gross margin is 71.81%, with operating and profit margins of 20.94% and 8.21%.
Gross Margin | 71.81% |
Operating Margin | 20.94% |
Pretax Margin | 11.08% |
Profit Margin | 8.21% |
EBITDA Margin | 29.45% |
EBIT Margin | 20.94% |
FCF Margin | 16.43% |
Dividends & Yields
This stock pays an annual dividend of 0.61, which amounts to a dividend yield of 4.22%.
Dividend Per Share | 0.61 |
Dividend Yield | 4.22% |
Dividend Growth (YoY) | 5.17% |
Years of Dividend Growth | 1 |
Payout Ratio | 94.91% |
Buyback Yield | -0.75% |
Shareholder Yield | 3.46% |
Earnings Yield | 4.42% |
FCF Yield | 8.84% |
Stock Splits
The last stock split was on July 19, 2022. It was a reverse split with a ratio of 0.8.
Last Split Date | Jul 19, 2022 |
Split Type | Reverse |
Split Ratio | 0.8 |
Scores
GSK plc has an Altman Z-Score of 1.81 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 1.81 |
Piotroski F-Score | 7 |